Amanda Napoles

Amanda Napoles assists clients with research and analysis to understand the latest developments in payment reform and care transformation initiatives.

She focuses on health system and provider impacts related to quality measurement, value-based payment, and alternative payment models. She applies her background in public health and health policy to a broad range of clients, including manufacturers, health plans, and specialty societies.

Prior to joining Avalere, Amanda was the program manager of payment programs at the American Academy of Neurology, where she led Quality Payment Program education efforts and developed specialty-specific alternative payment models. She previously worked as a qualitative researcher at the University of Minnesota’s State Health Access Data Assistance Center, where she contributed to the State Innovation Models evaluation, which aimed to transform Minnesota Medicaid and achieve accountable health goals. Additionally, she worked at the Urban Institute, where, among other initiatives, she managed a large government contract to provide analysis, training, and other technical assistance to key CMS and State Medicaid Agency staff.

Amanda earned a BA in political science from UC Santa Barbara and an MPH from the George Washington University’s Milken Institute School of Public Health.

Authored Content

The CDC recommends HBV vaccinations for persons with a history of current or recent injection drug use, but uptake remains low. Avalere research shows an opportunity to leverage alternative care settings to address the growing rates of HBV infection.

As one of the most common chronic conditions in the US—affecting approximately 10.5% of the US population and growing—diabetes (and the optimal management of this condition) remain a persistent healthcare challenge.1

Grantees will evaluate models for transforming health systems to promote health equity for Medicaid populations.

Avalere is releasing a new research agenda to guide evidence generation for health system models of care that advance the intersection of social and clinical needs of Medicaid-eligible individuals.

In December 2019, Avalere Health and Endocrine Society launched the first quality measurement set designed to help providers assess how well they identify and care for older adults at greater risk of hypoglycemia – low blood sugar that can be a dangerous complication of diabetes.

Major catastrophes, like natural disasters, global pandemics, and sudden economic downturns require rapid interventions to protect the American public from long-term health and financial damage. Because there is significant momentum and political will during and immediately following a catastrophe, promising innovations may be fast-tracked.

Avalere Health and the Endocrine Society launch hypoglycemia clinical tools.

Electronic health record (EHR) platforms continue to accelerate the transformation of healthcare by streamlining access to patient records, improving clinical outcomes, and fostering better decision-making at the point of care.

Avalere collaborates with the Endocrine Society and Pottstown Medical Specialists to launch a quality improvement intervention study aimed at addressing care gaps in the identification and management of hypoglycemia in older adults with type 2 diabetes.

On July 9, Health & Human Services (HHS) announced the formation of the Quality Summit (QS), as directed by a recent executive order aimed at improving price and quality transparency.

On May 24, Avalere policy experts published a piece on the Health Affairs blog highlighting opportunities to leverage quality measurement tied to payment to drive adult immunization uptake and achieve national population health targets.

A proposed rule released by the Treasury Department, Department of Labor, and Department of Health and Human Services would expand the allowed uses of employer-sponsored Health Reimbursement Arrangements (HRA). Comments on the rule can be submitted until December 28, 2018.